Proteomic Analysis of a NAP1 Clostridium difficile Clinical Isolate Resistant to Metronidazole

• Patrick M. Chong,

  Affiliation Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Tarah Lynch,

  Affiliation Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Stuart McCorrister,

  Affiliation Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Pamela Kibsey,

  Affiliation Victoria General Hospital, Victoria, British Columbia, Canada

  ⨯
• Mark Miller,

  Affiliation Jewish General Hospital, Montreal, Quebec, Canada

  ⨯
• Denise Gravel,

  Affiliation Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Garrett R. Westmacott,

  Affiliation Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• Michael R. Mulvey ,

  * E-mail: Michael_mulvey@phac-aspc.gc.ca

  Affiliation Public Health Agency of Canada, Winnipeg, Manitoba, Canada

  ⨯
• the Canadian Nosocomial Infection Surveillance Program (CNISP)

  ¶Membership of the Canadian Nosocomial Infection Surveillance Program (CNISP) is provided in the Acknowledgments.

  ⨯